Interaction between MUC1 and STAT1 drives IFITM1 overexpression in aromatase inhibitor-resistant breast cancer cells

被引：1
|
作者：
Lui, Asona
Lewis-Wambi, Joan
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-2918
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2918
引用
收藏
页数：4
相关论文
共 50 条
  • [31] GATA3 protein as a MUC1 transcriptional regulator in breast cancer cells
    Martín C Abba
    María I Nunez
    Andrea G Colussi
    María V Croce
    Amada Segal-Eiras
    C Marcelo Aldaz
    Breast Cancer Research, 8
  • [32] Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells
    Schaber, JD
    Fang, H
    Xu, J
    Grimley, PM
    Rui, H
    CANCER RESEARCH, 1998, 58 (09) : 1914 - 1919
  • [33] Tannic acid inhibits EGFR/STAT1/3 and enhances p38/STAT1 signalling axis in breast cancer cells
    Darvin, Pramod
    Joung, Youn Hee
    Kang, Dong Young
    Sp, Nipin
    Byun, Hyo Joo
    Hwang, Tae Sook
    Sasidharakurup, Hema
    Lee, Chi Ho
    Cho, Kwang Hyun
    Park, Kyung Do
    Lee, Hak Kyo
    Yang, Young Mok
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2017, 21 (04) : 720 - 734
  • [34] Crosstalk between MUC1 oncoprotein and ER, PR, and HER2 receptors in breast cancer cells
    Jalili, N.
    Naseri, N.
    Farahmand, L.
    Shokrollahy, M.
    Jafarbeik-Iravani, N.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S133 - S134
  • [35] Sphingosine Kinase 1 Regulates the Survival of Breast Cancer Stem Cells and Non-stem Breast Cancer Cells by Suppression of STAT1
    Hii, Ling-Wei
    Chung, Felicia Fei-Lei
    Mai, Chun Wai
    Yee, Zong Yang
    Chan, Hong Hao
    Raja, Vijay Joseph
    Dephoure, Noah Elias
    Pyne, Nigel J.
    Pyne, Susan
    Leong, Chee-Onn
    CELLS, 2020, 9 (04)
  • [36] BLM overexpression as a predictive biomarker for CHK1 inhibitor response in PARP inhibitor-resistant BRCAmutant ovarian cancer
    Gupta, Nitasha
    Huang, Tzu-Ting
    Nair, Jayakumar. R. R.
    An, Daniel
    Zurcher, Grant
    Lampert, Erika. J. J.
    McCoy, Ann
    Cimino-Mathews, Ashley
    Swisher, Elizabeth. M. M.
    Radke, Marc. R. R.
    Lockwood, Christina. M. M.
    Reichel, Jonathan. B. B.
    Chiang, Chih-Yuan
    Wilson, Kelli. M. M.
    Cheng, Ken Chih-Chien
    Nousome, Darryl
    Lee, Jung-Min
    SCIENCE TRANSLATIONAL MEDICINE, 2023, 15 (701)
  • [37] Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner
    Joshua Ogony
    Hye Joung Choi
    Asona Lui
    Massimo Cristofanilli
    Joan Lewis-Wambi
    Breast Cancer Research, 18
  • [38] Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy"
    Tian, Tian
    MOLECULAR PHARMACEUTICS, 2023, 20 (02) : 1447 - 1448
  • [39] Codelivery of Gemcitabine and MUC1 Inhibitor Using PEG-PCL Nanoparticles for Breast Cancer Therapy
    Behl, Akanksha
    Sarwalia, Parul
    Kumar, Sushil
    Behera, Chittaranjan
    Mintoo, Mubashir Javed
    Datta, Tirtha Kumar
    Gupta, Prem N.
    Chhillar, Anil K.
    MOLECULAR PHARMACEUTICS, 2022, : 2429 - 2440
  • [40] Interferon-induced transmembrane protein 1 (IFITM1) overexpression enhances the aggressive phenotype of SUM149 inflammatory breast cancer cells in a signal transducer and activator of transcription 2 (STAT2)-dependent manner
    Ogony, Joshua
    Choi, Hye Joung
    Lui, Asona
    Cristofanilli, Massimo
    Lewis-Wambi, Joan
    BREAST CANCER RESEARCH, 2016, 18
12345